These individuals had earlier cognitive decline and earlier clinical symptoms of AD compared with the 79.1% of DS individuals without the APOE ε4 allele [59], similar to findings in the general population and previous reports in individuals with DS [60–66]. The gene discussed is APOE; the disease is Alzheimer disease.